EHC/X
Oct 17, 2025, 08:28
EHC New Tech 2025: Join to Explore Advances in Bleeding Disorders Treatments
The European Haemophilia Consortium (EHC) shared on X:
”Just two weeks to the EHC New Tech 2025!
Join us on Oct 31–Nov 2 in Ljubljana to explore advances in Bleeding Disorders treatments.
Limited to EHC NMOs and HCPs—secure your spot!”
New products for bleeding disorders are expected to enter the European market in the future.
EHC New Tech 2025 will explore the underlying technologies of these innovations and examine strategies to ensure patient access—particularly focusing on their economic sustainability.
Don’t miss it! Register here.
Stay updated with Hemostasis Today.
-
Jun 4, 2026, 13:54Yaariv Khaykin: AI ECG Analysis Uncovers Hidden AF Associated With Future Stroke Risk
-
Jun 4, 2026, 13:50Gene Nudelman: Can a Hemostatic Gauze Perform When Blood Clotting is Impaired?
-
Jun 4, 2026, 13:45Edward Lee Carter: The First-Ever AHA/ACC Acute PE Guideline Is Here
-
Jun 4, 2026, 13:38Denis Oduor: The Role of Expectant Fathers in Saving Mothers and Newborns
-
Jun 4, 2026, 13:36Mohammad Reza Moghaddasnejad: Platelet Activation as a Key Driver of Breast Cancer Progression
-
Jun 4, 2026, 13:31Fredrick Chalinga: Microcytic Anemia Does Not Always Mean Iron Deficiency
-
Jun 4, 2026, 13:23How Access to Care Changed One Life – WFH
-
Jun 4, 2026, 13:16Muhammad Usman Arshad: Meta-Analysis Supports Expanding Role of DOACs in Cancer-Associated Thromboembolism
-
Jun 4, 2026, 12:59Dual Prognostic Significance of P2RY12 in Antithrombotic-Treated STEMI – JTH